scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00259-009-1260-4 |
P698 | PubMed publication ID | 19760414 |
P50 | author | Umberto Veronesi | Q780378 |
Viviana Galimberti | Q33275494 | ||
Giovanni Paganelli | Q43039252 | ||
Rita De Santis | Q56441584 | ||
Giuseppina A Di Dia | Q84390417 | ||
Roberto Orecchia | Q105532303 | ||
P2093 | author name string | Alberto Luini | |
Concetta De Cicco | |||
Marta Cremonesi | |||
Stefano Zurrida | |||
Gianmatteo Pagani | |||
Giuseppe Carbone | |||
Maria Cristina Leonardi | |||
Annamaria Ferrari | |||
Monica Pacifici | |||
Mahila E Ferrari | |||
P2860 | cites work | Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials | Q29031162 |
The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology | Q29615701 | ||
Estimates of radiation-absorbed dose to kidneys in patients treated with 90Y-ibritumomab tiuxetan | Q34117144 | ||
Accelerated treatment of breast cancer | Q34205264 | ||
Intraoperative avidination for radionuclide therapy: a prospective new development to accelerate radiotherapy in breast cancer | Q34689002 | ||
Standard for breast conservation therapy in the management of invasive breast carcinoma | Q34938061 | ||
Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review | Q35057465 | ||
TARGeted Intraoperative radiotherapy (TARGIT): an innovative approach to partial-breast irradiation | Q36089129 | ||
Conservative treatment of breast cancer: its evolution. | Q36301200 | ||
Antibody pretargeting advances cancer radioimmunodetection and radioimmunotherapy. | Q36354606 | ||
Dosimetry in Peptide radionuclide receptor therapy: a review. | Q36586256 | ||
MIRD pamphlet No. 20: the effect of model assumptions on kidney dosimetry and response--implications for radionuclide therapy. | Q40035683 | ||
Treatment of local breast carcinoma in Florida: the role of the distance to radiation therapy facilities | Q40369648 | ||
Conservation approaches for the management of stage I/II carcinoma of the breast: Milan Cancer Institute trials | Q43465146 | ||
Pre-targeted locoregional radioimmunotherapy with 90Y-biotin in glioma patients: phase I study and preliminary therapeutic results | Q43686600 | ||
Adequate locoregional treatment for early breast cancer may prevent secondary dissemination | Q44373547 | ||
Combined treatment of glioblastoma patients with locoregional pre-targeted 90Y-biotin radioimmunotherapy and temozolomide | Q45119704 | ||
Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose-effect relationship | Q45226554 | ||
Natural antibodies to avidin in human serum | Q46227206 | ||
The impact of radiation on early breast carcinoma survival. A Bayesian analysis. | Q50615497 | ||
Biologic comparison of partial breast irradiation protocols. | Q51982632 | ||
The effect of delay in treatment on local control by radiotherapy. | Q52314322 | ||
Detection of prosthetic vascular graft infection using avidin/indium-111-biotin scintigraphy | Q70845146 | ||
Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) | Q72149116 | ||
Antibodies against biotinylated proteins are present in normal human serum | Q72304086 | ||
Biodistribution in tumour-bearing mice of two 90Y-labelled biotins using three-step tumour targeting | Q73169052 | ||
Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery | Q73402074 | ||
Avidin targeting of intraperitoneal tumor xenografts | Q74038702 | ||
Clinical validation of the avidin/indium-111 biotin approach for imaging infection/inflammation in orthopaedic patients | Q77885236 | ||
Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer | Q78410812 | ||
IART: intraoperative avidination for radionuclide treatment. A new way of partial breast irradiation | Q79437754 | ||
The radiobiology of conventional radiotherapy and its application to radionuclide therapy | Q81546873 | ||
OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine | Q81816056 | ||
Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery: experience with 590 cases | Q81880890 | ||
P433 | issue | 2 | |
P1104 | number of pages | 9 | |
P304 | page(s) | 203-211 | |
P577 | publication date | 2009-09-04 | |
P1433 | published in | European Journal of Nuclear Medicine and Molecular Imaging | Q15708890 |
P1476 | title | Intraoperative avidination for radionuclide treatment as a radiotherapy boost in breast cancer: results of a phase II study with (90)Y-labeled biotin | |
P478 | volume | 37 |
Q84790091 | 3D dosimetry in patients with early breast cancer undergoing Intraoperative Avidination for Radionuclide Therapy (IART) combined with external beam radiation therapy |
Q38967404 | AvidinOX-anchored biotinylated trastuzumab and pertuzumab induce down-modulation of ErbB2 and tumor cell death at concentrations order of magnitude lower than not-anchored antibodies. |
Q30384834 | Biochemical and biological characterization of a new oxidized avidin with enhanced tissue binding properties. |
Q90455060 | Combined external beam radiotherapy with carbon ions and tumor targeting endoradiotherapy |
Q47403446 | Design and solid phase synthesis of new DOTA conjugated (+)-biotin dimers planned to develop molecular weight-tuned avidin oligomers |
Q39424591 | Development of sentinel node biopsy, ROLL and IART in early breast cancer at the European Institute of Oncology, Milan (IEO). |
Q38383207 | Intraoperative radiotherapy in early breast cancer |
Q44102830 | Investigation of 90Y-avidin for prostate cancer brachytherapy: a dosimetric model for a phase I-II clinical study. |
Q64245291 | Lectin-Mediated pH-Sensitive Doxorubicin Prodrug for Pre-Targeted Chemotherapy of Colorectal Cancer with Enhanced Efficacy and Reduced Side Effects |
Q35249333 | Post-lumpectomy intracavitary retention and lymph node targeting of (⁹⁹m)Tc-encapsulated liposomes in nude rats with breast cancer xenograft |
Q39572340 | Preclinical pharmacology and safety of a novel avidin derivative for tissue-targeted delivery of radiolabelled biotin |
Q42477444 | Therapeutic Use of Avidin Is Not Hampered by Antiavidin Antibodies in Humans |
Q84994601 | Therapeutic nuclear medicine expands to breast cancer |
Q39084057 | Triazole biotin: a tight-binding biotinidase-resistant conjugate |